en

PRODUCT DETAIL

KRAZATI 200 mg filmom obalené tablety

Code 5246E
MA number EU/1/23/1744/002
Product Form: tbl flm 180x200 mg (fľ.HDPE)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX77 Adagrasib
Shelf life: 24
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 05.01.2024
Validity: 05.01.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 17.01.2024
eu-flag.png sk-flag.png